2 25 Abstract 26 NR4A is a nuclear receptor protein family whose members act as sensors of cellular 27 environment and regulate multiple processes such as metabolism, proliferation, migration, 28 apoptosis, and autophagy. Since the ligand binding domains of these receptors have no 29 cavity for ligand interaction, their function is most likely regulated by protein abundance 30 and post-translational modifications. In particular, NR4A1 is regulated by protein 31 abundance, phosphorylation, and subcellular distribution (nuclear-cytoplasmic 32 translocation), and acts both as a transcription factor and as a regulator of other 33 interacting proteins. SUMOylation is a post-translational modification that can affect protein 34 stability, transcriptional activity, alter protein-protein interactions and modify intracellular 35 localization of target proteins. In the present study we evaluated the role of SUMOylation 36 as a posttranslational modification that can regulate the activity of NR4A1 to induce 37 autophagy-dependent cell death. We focused on a model potentially relevant for neuronal 38 cell death and demonstrated that NR4A1 needs to be SUMOylated to induce autophagic 39 cell death. We observed that a triple mutant in SUMOylation sites has reduced 40 SUMOylation, increased transcriptional activity, altered intracellular distribution, and more 41 importantly, its ability to induce autophagic cell death is impaired. 42 43 Summary Statement 44 The modification of the nuclear receptor NR4A1 by SUMO regulates its transcriptional 45 activity, intracellular localization and is required to induce autophagic cell death.
7 142 (28, 29). Therefore, we hypothesize that NR4A1 might be SUMOylated in response to 143 SP/NK 1 R signaling, conferring upon it the ability to induce autosis.
144
SUMOs are small ubiquitin-related peptides, approximately 11 KDa size, that 145 become conjugated to a variety of proteins and are deconjugated by SUMO-specific 146 proteases. Despite the name, SUMO shares less than 20% homology with ubiquitin. The 147 similarity is more significant in the biochemical mechanism of ligation, as it involves three 148 conjugating enzymes: E1, a dimer known as SAE1/SAE2; E2, a protein named UBC9; and
149 E3, which are a group of proteins conferring target specificity. There are four genes in 150 mammals coding for four SUMO peptides (SUMO1-4). SUMO2 and 3 share 95% 151 homology and there are no antibodies that distinguish between them, so they are referred 152 to as SUMO2/3; they are only 50% identical to SUMO1 (reviewed in (30)).
153
NR4A1 is an early response gene, whose expression is induced in minutes, and the 154 protein is degraded after a couple of hours. However, we observed that NR4A1 expression 155 is sustained during SP/NK 1 R-induced autosis, suggesting that in this scenario NR4A1
156 protein would scape degradation. In this work, we confirmed that NR4A1 is indeed 157 SUMOylated during SP/NK 1 R-induced autosis, and mutants with reduced SUMOylation 158 showed increased transcriptional activity and altered intracellular distribution. More 159 importantly, the ability to promote SP/NK 1 R-induced autosis was impaired when 259 and hence it is also a potential site for SUMOylation in NR4A1 (positions numbers refer to 260 the human canonic sequence UniProtKB P22736) ( Figure 1A ).
261
To analyze NR4A1 SUMOylation during SP/NK 1 R-induced autosis, we 262 immunoprecipitated NR4A1 at different time points after SP exposure and looked for 263 SUMO1 or SUMO2/3 conjugation by Western blot. Starting at 3 hr after SP induction, a 264 fraction of NR4A1 was SUMOylated by SUMO1 and the modification lasted up to 12 hr, a 265 time point at which SUMO2/3 ligation was also observed ( Figure 1B ). We verified that 266 SUMO peptide conjugation of NR4A1 occurs during SP/NK 1 R-induced autosis by over-267 expressing Myc-tagged SUMO1 ( Figure 1C ) or HA-tagged SUMO2 ( Figure 1D ). To study 268 the role of SUMOylated NR4A1 we substituted the three lysine residues expected to be 269 modified by SUMO (K102, K558 and K577) for arginine. First, we evaluated whether the 270 triple NR4A1_K102,558,577R mutant (named TriMut) had reduced SUMOylation in 12 271 comparison to the level determined in NR4A1 wild type. We immunoprecipitated FLAG-272 NR4A1 wild type or FLAG-NR4A1_TriMut and looked for the presence of SUMO2 by 273 Western blot. Indeed, NR4A1_TriMut showed reduced SUMOylation ( Figure 1D ), although 274 additional Lys residues seem to be also modified by SUMO, as a weak signal was still 275 detected. 279 which is necessary for autosis induction, as the inhibition of MEK2 and ERK2 (but not the 280 inhibition of MEK1 or ERK1) prevents NR4A1 phosphorylation and SP/NK 1 R-induced 281 autosis (12). Accordingly, NR4A1 is phosphorylated in vitro by ERK2 but not by ERK1 in 282 threonine 143 (35). Therefore, we mutated T143 to alanine, expecting to abolish its 283 phosphorylation. Indeed, T143 is phosphorylated during SP/NK 1 R-induced autosis, since 284 mutant NR4A1_T143A had reduced phosphorylation level as compared to NR4A1 wild 285 type ( Figure 2A ). Nevertheless, a weak signal was still observed, indicative of an additional 286 phosphorylated threonine. We found two additional ERK consensus motifs in the NR4A1 287 sequence ( Figure 1A ), although additional phosphorylation sites could be targeted by 288 other kinases.
289
To analyze whether SUMO conjugation influences phosphorylation, we studied the 290 level of phosphorylation when SUMOylation is reduced. As shown in Figure 2A , the level 291 of phosphorylation on threonine residues was not affected in NR4A1_TriMut. This result 292 indicates that phosphorylation is not affected by SUMOylation in this case. On the other 293 hand, SUMOylation resulted dependent on previous phosphorylation in T143, as 294 NR4A1_T143A was barely SUMOylated ( Figure 2B ). Therefore, NR4A1 SUMOylation, 295 subsequent to phosphorylation, could alter NR4A1 stability and/or intracellular distribution 296 and, consequently, the ability to induce autosis.
297
In previous work we observed that Nr4a1 expression is induced by SP signaling 298 (12), but NR4A1 protein abundance cannot be explained by transcriptional regulation 299 alone. We noticed that NR4A1 produced by expression of its cDNA (lacking both 5' and 3' 300 UTR) from a viral promoter (CMV) that lacks endogenous regulatory regions, also 301 accumulates in response to SP/NK 1 R (for example, look at Figure 2A , Input). We 302 rationalized then that NR4A1 stability should be post-translationally regulated. MAPK 303 signaling activated by SP/NK 1 R does not affect NR4A1 abundance, as it still accumulates 304 when ERK2 signaling is inhibited (12). SUMO modification commonly enhances protein 305 stability by binding to lysine residues that otherwise would be ubiquitinated, targeting the 306 protein for proteasome degradation; nevertheless, it has also been observed that some E3
307 ubiquitin ligases, such as RNF4, which have both SIM (SUMO interacting motif) and RING 308 domains, attach ubiquitin to SUMO-modified proteins (30), and this mechanism has been 309 described to occur to NR4A1(26). Therefore, we asked whether NR4A1 SUMOylation 310 regulated NR4A1 stability during SP/NK 1 R-induced autosis. First, we determined the 311 endogenous NR4A1 half-life. NR4A1 reached a maximum level of expression 3 hr after SP 312 exposure and by 9 hr it was still detected but clearly reduced ( Figure 2C ). We then 313 inhibited new protein synthesis (with cycloheximide) after 3 hr of induction with SP (to start 314 with the highest amount of NR4A1), and observed that NR4A1 was degraded very rapidly, 315 as 3 hr after cycloheximide addition it was no longer detected ( Figure 2C ).
316
To compare the half-life of wild type NR4A1 with NR4A1_TriMut with reduced 317 SUMOylation, we tagged it with FLAG, and compared FLAG-NR4A1 wild-type half-life with 318 FLAG-NR4A1_TriMut (which allowed to distinguish NR4A1_TriMut from endogenously 319 induced NR4A1). Since these constructs are expressed from a strong constitutive 320 promoter (CMV), FLAG-NR4A1 started in these experiments with a higher amount of 321 protein than the endogenously-induced NR4A1, therefore its expression could be 328 degradation rate. Other reports describe that NR4A1 stability can be modulated by 329 acetylation, which also occurs at Lys residues. We looked for acetylation during SP/NK 1 R-330 induced autosis, but no difference was found in the level of acetyl-Lysine content in 331 immunoprecipitated NR4A1 from non-treated cells compared with SP treated cells (data 332 not shown). We do not know at this point which mechanism mediates the increase in 333 NR4A1 stability in response to SP signaling but, possibly, the remaining SUMOylation 334 sites observed in TriMut ( Figure 1D ) could be involved. 349 transcriptional activity, and then we compared its transcriptional activity with that of NR4A1 350 WT in response to SP. As can be seen in Figure 3A , NR4A1_TriMut showed enhanced 351 transcriptional activity in response to SP signaling. Therefore, SUMOylation appears to be 352 a relevant negative regulator of NR4A1 transcriptional activity.
353
NR4A1 can have both nuclear and cytoplasmic functions(15); during SP/NK 1 R-354 induced autosis around 15% of the cells showed NR4A1 also in the cytoplasm (13). To 355 assess whether SUMOylation affects NR4A1 localization, we analyzed the intracellular 356 distribution of the TriMut. In accordance with the higher level of transcriptional activity we 357 observed, the TriMut was more frequently retained in the nucleus. We also tested the 358 mutant in the target of phosphorylation T143, as it has been previously reported that 359 phosphorylation of NR4A1 also modulates its localization, although in response to other 360 kinases and phosphorylated in other sites (38). We compared NR4A1_T143A and 361 NR4A1_T143D, phosphorylation-defective and threonine phosphorylation-mimic (D mimics 362 the negative charge provided by phosphorylation) mutants, respectively. While most of the 363 cells have NR4A1 restricted to the nucleus, again we observed a small proportion (18%) of 364 cells with NR4A1 also in the cytoplasm ( Figure 3B ). It appears then than SUMOylation 365 regulates the exportation of NR4A1 out of the nucleus, while phosphorylation might be 366 necessary for retaining NR4A1 in the nucleus. A fine regulation of combined PTMs could 367 determine the intracellular distribution of NR4A1.
368 369 NR4A1 SUMOylation is necessary for SP-induced autosis 370 We hypothesized that the signaling pathway activated upon NK 1 R activation by SP binding 371 triggers SUMOylation of NR4A1, conferring upon it the ability to induce autosis instead of 372 apoptosis or proliferation, among other processes. To inhibit NR4A1 SUMOylation we 373 expressed GAM1, a viral protein that inhibits SUMOylation by promoting SAE1/SAE2 and 374 UBC9 degradation (39). As shown in Figure 4A , in the presence of GAM1, but not of an 16 375 inactive GAM1 mutant, the amount of SUMOylated NR4A1 was reduced. Supporting the 376 notion that SUMOylation increases its basal stability, the total amount of NR4A1 was also 377 reduced in the presence of GAM1. More significantly, Gam1 expression completely 378 prevented SP/NK 1 R-induced autosis ( Figure 4B ).
379
Finally, to confirm whether SUMOylation of NR4A1 is indeed necessary to mediate 380 SP-induced autosis, we tested the ability of TriMut to induce autosis in response to SP. To 381 eliminate endogenous expression of NR4A1 that could mask the mutant phenotype, we 382 silenced it by targeting small interfering RNAs to the 3' untranslated region of RN4A1
383 mRNA, which is absent in the NR4A1 expression vector. As expected, silencing the 384 expression of endogenous NR4A1 reduced cell death in response to SP, which was 385 restored by the expression of NR4A1 WT but not by the expression of TriMut ( Figure 4C ).
386 Therefore, SUMOylation of NR4A1 is necessary for SP/NK 1 R-induced autosis. 
